美国 - 英文 - NLM (National Library of Medicine)

medimetriks pharmaceuticals, inc. - ciclopirox olamine (unii: 50md4sb4ap) (ciclopirox - unii:19w019zdrj) - ciclopirox 7.7 mg in 1 ml - loprox® topical suspension is indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum, and microsporum canis; ; cutaneous candidiasis (moniliasis) due to candida albicans; and tinea (pityriasis) versicolor due to malassezia furfur. loprox® topical suspension is contraindicated in individuals who have shown hypersensitivity to any of its components.

美国 - 英文 - NLM (National Library of Medicine)

alvogen inc. - felbamate (unii: x72rbb02n8) (felbamate - unii:x72rbb02n8) - felbamate 400 mg - felbamate tablets, usp are not indicated as a first line antiepileptic treatment (see warnings). felbamate tablets are recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use. if these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgment, felbamate tablets can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with lennox-gastaut syndrome in children. felbamate tablets are contraindicated in patients with known hypersensitivity to felbamate, its ingredients, or known sensitivity to other carbamates. it should not be used in patients with a history of any blood dyscras

美国 - 英文 - NLM (National Library of Medicine)

xspire pharma, llc - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin 0.5 mg in 0.25 ml - ciprofloxacin otic solution is a quinolone antimicrobial indicated for the treatment of acute otitis externa due to susceptible isolates of pseudomonas aeruginosa or staphylococcus aureus . ciprofloxacin otic solution is contraindicated in persons with a history of hypersensitivity to ciprofloxacin. pregnancy category c. reproduction studies have been performed in rats and mice using oral doses of up to 100 mg/kg and intravenous (iv) doses up to 30 mg/kg and have revealed no evidence of harm to the fetus as a result of ciprofloxacin. in rabbits, ciprofloxacin (30 and 100 mg/kg orally) produced gastrointestinal disturbances resulting in maternal weight loss and an increased incidence of abortion, but no teratogenicity was observed at either dose. after intravenous administration of doses up to 20 mg/kg, no maternal toxicity was produced in the rabbit, and no embryotoxicity or teratogenicity was observed. animal reproduction studies have not been conducted with ciprofloxacin otic solution. no adequate and well

美国 - 英文 - NLM (National Library of Medicine)

mylan institutional inc. - acyclovir (unii: x4hes1o11f) (acyclovir - unii:x4hes1o11f) - acyclovir 50 mg in 1 g - acyclovir ointment 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients. acyclovir ointment 5% is contraindicated in patients who develop hypersensitivity to the components of the formulation.

美国 - 英文 - NLM (National Library of Medicine)

novel laboratories, inc. - tinidazole (unii: 033kf7v46h) (tinidazole - unii:033kf7v46h) - tinidazole 250 mg - tinidazole is indicated for the treatment of trichomoniasis caused by trichomonas vaginalis. the organism should be identified by appropriate diagnostic procedures. because trichomoniasis is a sexually transmitted disease with potentially serious sequelae, partners of infected patients should be treated simultaneously in order to prevent re-infection [see clinical studies ( 14.1 )]. tinidazole is indicated for the treatment of giardiasis caused by giardia duodenalis (also termed g. lamblia ) in both adults and pediatric patients older than three years of age [see clinical studies ( 14.2 ) ]. tinidazole is indicated for the treatment of intestinal amebiasis and amebic liver abscess caused by entamoeba histolytica in both adults and pediatric patients older than three years of age. it is not indicated in the treatment of asymptomatic cyst passage [see clinical studies ( 14.3 , 14.4 ) ]. tinidazole is indicated for the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardn

美国 - 英文 - NLM (National Library of Medicine)

lupin pharmaceuticals,inc. - tinidazole (unii: 033kf7v46h) (tinidazole - unii:033kf7v46h) - tinidazole 250 mg - tinidazole is indicated for the treatment of trichomoniasis caused by trichomonas vaginalis. the organism should be identified by appropriate diagnostic procedures. because trichomoniasis is a sexually transmitted disease with potentially serious sequelae, partners of infected patients should be treated simultaneously in order to prevent re-infection [see clinical studies ( 14.1)]. tinidazole is indicated for the treatment of giardiasis caused by giardia duodenalis (also termed g. lamblia ) in both adults and pediatric patients older than three years of age [see clinical studies ( 14.2) ]. tinidazole is indicated for the treatment of intestinal amebiasis and amebic liver abscess caused by entamoeba histolytica in both adults and pediatric patients older than three years of age. it is not indicated in the treatment of asymptomatic cyst passage [see clinical studies ( 14.3, 14.4) ]. tinidazole is indicated for the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardnerella

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; calcium chloride dihydrate; trometamol; water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

美国 - 英文 - NLM (National Library of Medicine)

biocomp pharma, inc. - sulfacetamide sodium (unii: 4nrt660kjq) (sulfacetamide - unii:4965g3j0f5), sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70) - sulfacetamide sodium 100 mg in 1 g - this product is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis. this product is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product. this product is not to be used by patients with kidney disease.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

hcs bvba - naproxen sodium - film coated tablet - 550 milligram - propionic acid derivatives

美国 - 英文 - NLM (National Library of Medicine)

cardinal health - lorazepam (unii: o26fzp769l) (lorazepam - unii:o26fzp769l) - lorazepam 0.5 mg - lorazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the effectiveness of lorazepam tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. lorazepam tablets are contraindicated in patients with